COPD

Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Bengtsson T, Rickard K, Sciurba F. Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment ...

By sjmartinez • August 16, 2023

Hansel NN, Woo H, Koehler K, Gassett A, Paulin LM, Alexis N, Putcha N, Lorizio W, Fawzy A, Belz D, Sack C, Barr RG, Martinez ...

By sjmartinez • August 1, 2023

Motahari A, Barr RG, Han MK, Anderson WH, Barjaktarevic I, Bleecker ER, Comellas AP, Cooper CB, Couper DJ, Hansel NN, Kanner RE, Kazerooni EA, Lynch ...

By sjmartinez • July 26, 2023

Park SC, Saiphoklang N, Phillips J, Wilgus ML, Buhr RG, Tashkin DP, Cooper CB, Barjaktarevic I. Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable ...

By sjmartinez • July 24, 2023

Tashkin DP. Age of Initiating Smoking: An Independent Predictor of COPD in Later Life. Am J Respir Crit Care Med. 2023 Jul 10. doi: 10.1164/rccm.202307-1146ED. ...

By sjmartinez • July 11, 2023

Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Bengtsson T, Rickard K, Sciurba F; ENHANCE investigators. Ensifentrine, a Novel PDE3 and PDE4 Inhibitor for the ...

By sjmartinez • June 27, 2023

Tashkin DP, Barjaktarevic I. Marijuana Use as a Risk Factor for COPD: Not There Yet. Am J Respir Crit Care Med. 2023 Jun 13. doi: ...

By sjmartinez • June 14, 2023

Arjomandi M, Zeng S, Chen J, Bhatt SP, Abtin F, Barjaktarevic I, Barr RG, Bleecker ER, Buhr RG, Criner GJ, Comellas AP, Couper DJ, Curtis ...

By sjmartinez • May 19, 2023

Izquierdo M, Marion CR, Genese F, Newell JD, O'Neal WK, Li X, Hawkins GA, Barjaktarevic I, Barr RG, Christenson S, Cooper CB, Couper D, Curtis ...

By sjmartinez • May 19, 2023

Barjaktarevic I, Cooper CB, Shing T, Buhr RG, Hoffman EA, Woodruff PG, Drummond MB, Kanner RE, Han MK, Hansel NN, Bowler RP, Kinney GL, Jacobson ...

By sjmartinez • May 19, 2023